Biomaterials are taking medicine by storm – explore some recent preclinical advances in the field that may yield therapeutic benefits.

Biomedical engineer advances sustainable wound care by converting chicken feather waste into biocompatible hydrogel ...

An announcement from NexGel Inc ( (NXGL) ) is now available.

NEXGEL, Inc. (NASDAQ:NXGL) has signed an asset purchase and exclusive licensing agreement with Celularity, Inc. to obtain rights to Celularity’s commercial-stage regenerative biomaterials portfolio, ...

NexGel Inc. NXGL on Tuesday agreed to license and acquire a portfolio of commercial-stage regenerative biomaterial products from Celularity, Inc. CELU, a regenerative and cellular medicine company.

Consideration for portfolio will consist of a $15 million upfront cash payment and potentially an additional $20 million in milestone payments ...

Experienced Team: An accomplished commercial and scientific team is expected to join NEXGEL as part of the transaction, significantly expanding the Company’s sales organization and bringing deep ...

Miniature organs grown in the lab can organize themselves into complex shapes, which enables scientists to use them to study disease. The trouble is they never do it the same way twice, which has made ...

Horses provide a strong translational model for human osteoarthritis -- Clinical investigation authorized by Belgian regulatory authority -- Allegro's hydrogel is first-in-class potentially ...